Inventor · disambiguated record
Richard Chesworth
Also filed as: CHESWORTH RICHARD
109 granted patents·60 pending applications·1,866 citations·filing 2000–2024
99Inventor score
Files withEPIZYME INC118ENVIVO PHARMACEUTICALS INC12FORUM PHARMACEUTICALS INC12CHESWORTH RICHARD5RIPKA AMY4
Top patents by PatentIndex Score
169 records- 0199US9475776B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Oct 25, 2016·32 cites·9 claims
- 0299US9365519B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Jun 14, 2016·34 cites·39 claims
- 0399US9206157B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2015·Granted Dec 8, 2015·28 cites·14 claims
- 0499US9120757B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 1, 2015·45 cites·36 claims
- 0599US9023883B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 5, 2015·46 cites·20 claims
- 0699US8993555B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 31, 2015·50 cites·4 claims
- 0799US8962620B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Feb 24, 2015·31 cites·10 claims
- 0899US8598167B1Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Dec 3, 2013·34 cites·12 claims
- 0998US9943504B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Apr 17, 2018·14 cites·17 claims
- 1098US9675614B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Jun 13, 2017·17 cites·23 claims
- 1198US9630961B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Apr 25, 2017·21 cites·24 claims
- 1298US9604930B2Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 28, 2017·21 cites·35 claims
- 1398US9549931B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jan 24, 2017·39 cites·21 claims
- 1498US9522152B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Dec 20, 2016·32 cites·8 claims
- 1598US9394258B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jul 19, 2016·39 cites·13 claims
- 1698US9365527B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jun 14, 2016·35 cites·33 claims
- 1798US9346802B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 24, 2016·38 cites·32 claims
- 1898US9133189B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 15, 2015·45 cites·20 claims
- 1998US9090562B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2014·Granted Jul 28, 2015·51 cites·20 claims
- 2098US8940726B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Jan 27, 2015·47 cites·22 claims
- 2198US8906900B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Dec 9, 2014·44 cites·18 claims
- 2298US8765732B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2012·Granted Jul 1, 2014·66 cites·19 claims
- 2397US10118931B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Nov 6, 2018·19 cites·4 claims
- 2497US9765035B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 19, 2017·15 cites·14 claims
- 2597US9718816B21-phenoxy-3-(alkylamino)-propan-2-ol derivatives as CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Aug 1, 2017·25 cites·28 claims
- 2697US9440950B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Sep 13, 2016·34 cites·16 claims
- 2797US9365555B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Jun 14, 2016·37 cites·18 claims
- 2897US9045455B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jun 2, 2015·46 cites·20 claims
- 2997US8410088B2Aryl- or heteroaryl-substituted benzene compoundsKUNTZ KEVIN W·Filed 2012·Granted Apr 2, 2013·96 cites·25 claims
- 3096US11052093B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2019·Granted Jul 6, 2021·7 cites·20 claims
- 3196US10155002B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2016·Granted Dec 18, 2018·16 cites·29 claims
- 3296US9868703B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Jan 16, 2018·15 cites·2 claims
- 3396US9856267B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Jan 2, 2018·14 cites·4 claims
- 3496US9855275B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2017·Granted Jan 2, 2018·18 cites·30 claims
- 3596US9732041B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Aug 15, 2017·17 cites·9 claims
- 3696US9598374B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Mar 21, 2017·25 cites·9 claims
- 3796US9447079B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 20, 2016·38 cites·13 claims
- 3896US9388173B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jul 12, 2016·32 cites·23 claims
- 3996US9346761B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 24, 2016·38 cites·36 claims
- 4096US9266836B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Feb 23, 2016·35 cites·28 claims
- 4196US9221794B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Dec 29, 2015·40 cites·17 claims
- 4296US8952026B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Feb 10, 2015·47 cites·20 claims
- 4395US10420775B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2017·Granted Sep 24, 2019·12 cites·20 claims
- 4495US9777008B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Oct 3, 2017·16 cites·22 claims
- 4595US9765068B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Sep 19, 2017·14 cites·27 claims
- 4695US9732072B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Aug 15, 2017·16 cites·19 claims
- 4795US9611257B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Apr 4, 2017·22 cites·16 claims
- 4894US10391089B2PRMT5 inhibitors and uses therofEPIZYME INC·Filed 2017·Granted Aug 27, 2019·5 cites·19 claims
- 4994US10307413B2Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Jun 4, 2019·5 cites·39 claims
- 5094US10273223B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2017·Granted Apr 30, 2019·5 cites·13 claims
Showing the top 50 of 169 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Richard Chesworth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →